We previously reported that
matrix metalloproteinase (MMP)-10
mRNA levels were significantly lower in
tumor tissues than in adjacent normal tissues in human
non-small cell lung cancer (NSCLC), whereas
protein levels of MMP-10 were higher in the
tumor tissues than the adjacent tissues. The mechanism of this divergence is still unknown. In the present study the role of
Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) on
interleukin (IL)-6 mediated regulation of MMP-10 expression was investigated in a human
lung adenocarcinoma cell line (A549 cells) and the molecular regulatory mechanism of MMP-10 expression was explored. A549 cells were stimulated by different concentrations of
IL-6 with or without
AG490, a specific JAK2 inhibitor. It was demonstrated that
IL-6 moderately reduced the MMP-10
mRNA levels, whereas it significantly enhanced the MMP-10
protein mass in the A549 cells. This phenomenon mimicked the divergence of
mRNA level and
protein mass of MMP-10 in human NSCLC. Moreover, the present study indicated that
IL-6 regulation of MMP-10 expression was via the JAK2/STAT3 pathway. STAT3
mRNA levels were significantly increased when the cells were treated with
IL-6, whereas when
AG490 (50 muM) was added to the cell cultures, IL-6-induced increase of STAT3
mRNA levels was abolished. Meanwhile,
AG490 blocked the IL-6-induced inhibition of MMP-10
mRNA as well as blocking the IL-6-induced increase of MMP-10
protein mass in the A549 cells. Neither
IL-6 nor
AG490 influenced JAK2
mRNA levels in the A549 cell cultures. It is concluded that the JAK2/STAT3 pathway is involved in the IL-6-mediated regulation of MMP-10, and
IL-6 can moderately reduce MMP-10
mRNA levels and strongly increase MMP-10
protein mass in human
lung adenocarcinoma A549 cells. Contrasting effects of
IL-6 on MMP-10
mRNA level and
protein concentration in A549 cells may partially explain the divergence of MMP-10
mRNA level and
protein mass in human NSCLC.